Key Drivers
- Strong Liquidity
- Narrowing Losses
- Persistent Deficit
AIAI Summary
SI-BONE is shifting toward an operating-leverage story—supported by 15% growth, expanding physician adoption, high gross margins, and initial positive operating cash flow—but investors should wait for repeated cash-flow and EBITDA progress, as its premium valuation remains vulnerable if new physicians fail to ramp utilization and expenses do not scale.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Liquidity
- •Narrowing Losses
- •Persistent Deficit
SIBN has strong liquidity and improving margins/cash flow, but persistent losses and a demanding valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Lower highs
- •Key support
- •Near oversold
SIBN is in a bearish last-month trend below its 21-day average, with $18.00–$18.05 support critical and a rebound requiring a break above $18.50–$18.70.
Mild uptick from $18.04 to $18.09
Sentiment & News
Key News Insights:
- •Earnings Upgrades
- •Target Upside
- •Investor Engagement
SI-Bone shows constructive momentum as rising earnings estimates and ~25% target upside are reinforced by management's healthcare conference participation.
The news is moderately positive for SIBN, supporting investor confidence while execution remains key
Similar Companies in Healthcare
Other companies in the same sector with AI ratings